The 2024 Best Small Firms to Work For: SSI Strategy

CLIENT INDUSTRIES SERVED: Life Sciences and Biotech Consulting

CONSULTING SERVICE LINES: Strategy and Operations Management

SSI Strategy combines business acumen, medical, clinical and pharmacovigilance domain expertise, and operating experience to provide unparalleled support to our clients. Our staff of ex-Chief Medical Officers and former Heads of Medical Affairs, Clinical Development and Safety will work to ensure the right balance of medical and business focus to drive unparalleled outcomes for clients.

CMAG: What characteristics and elements would you attribute to your firm's inclusion as a Best Firm to Work For?

Being featured on the Best Small Firms to Work For list for the 4th consecutive year underscores SSI Strategy's commitment to its people. We strive to create an environment where everyone feels respected, supported, and empowered to do their most impactful work. By fostering diversity of thought and an entrepreneurial spirit, we enable our teams to collaborate effectively and innovate solutions for our clients' complex challenges. We believe that highly engaged employees are the key to driving success, and we continually work to nurture a culture that promotes connection, dedication, and growth.

Despite the challenges posed by a largely virtual model and the merger we experienced last year, we have maintained a strong sense of engagement and collaboration. This is achieved through our focus on providing learning and development opportunities, encouraging open communication, and delivering high-quality work that makes a difference for our clients. We regularly host events and initiatives based on team feedback, such as All Hands Meetings, Collaboration Days, and team-building activities. The merger has presented our colleagues with new opportunities to collaborate and grow, and we have successfully navigated this year of change by keeping our team engaged and excited about the future. Our commitment to our people remains unwavering, and we believe this is the foundation of our continued success as a Best Firm to Work For.

CMAG: Are there any specific programs or initiatives that contributed to you being included as a Best Firm?

In addition to maintaining a strong culture within the firm, our team takes great pride in the impact we have on the science we assist our clients with.

As a firm, we view our client's success as our success, and this year, we have had even more opportunities to celebrate these achievements with the expansion of our capabilities through the merger with NDA Group. The merger has created new avenues for collaboration, learning, and growth for our staff, presenting them with exciting challenges and the chance to forge new friendships with colleagues across the globe. Our teams have been able to leverage the combined expertise of both organizations to support our clients in navigating the complexities of the biotech industry, from early-stage development strategies to successful regulatory submissions.

Over the past year, our integrated teams have contributed to numerous client successes, including IND filings, clinical program starts, medical product launches, and more. We have supported FDA fast track designations, led first in-house clinical trials, and played a key role in successful MAA/BLA submissions. The trust our clients place in our teams is evident through the many repeat engagements and referrals we receive.

To foster the spirit of collaboration and knowledge sharing, we have implemented initiatives such as cross-functional project teams, global training programs, and mentorship opportunities. These initiatives have not only enhanced our ability to deliver exceptional results for our clients but have also provided our staff with new avenues for professional growth and development.

As we celebrate the 1-year anniversary of our merger, we are proud of the way our teams have come together to create a stronger, more dynamic organization that is better equipped to support our clients and provide our staff with rewarding career opportunities.

CMAG: In describing your firm, what would you say sets it apart from other consulting firms?

SSI Strategy stands out in the biotech consulting space due to our unique blend of experienced medical, scientific, and regulatory experts, including former CMOs, seasoned physicians, Ph.Ds., and regulators, as well as our talented team of business consultants. This diverse expertise allows us to provide a differentiated business model, serving as a skill-building, enablement, and operator platform for biotechs. We work alongside our clients to minimize risks and maximize value across the drug development lifecycle, offering leadership and fit-for-purpose solutions that seamlessly integrate with their existing capabilities.

Our flexible support model, called "Build – Scale – Transition," is designed to adapt to the specific needs of each client, providing the necessary expertise, resources, and guidance at every stage of their growth. We work hand-in-hand with our clients to establish a roadmap and execution strategy (Build), integrate professionals into projects as needed (Scale), and flex in and out to provide a smooth transition as the client strengthens their internal capabilities (Transition).

At SSI Strategy, we tailor our approach to support various leadership roles within biotech companies, including Board Members, CEOs, CMOs, and Functional Leaders. Our team provides strategic guidance, operational support, and deep industry knowledge to help these leaders navigate the complexities of the life sciences industry and achieve their goals. We emphasize our commitment to being more than just a service provider – we aim to be a true partner in "Building Better Biotechs," working closely with our clients to overcome obstacles, seize opportunities, and realize the full potential of their innovative therapeutics.

CMAG: Where your workforce is concerned, what would you say your priorities look like for the upcoming year and beyond?

Our top priority is to build on the momentum we've established, driving even greater achievements in service of our clients. We are focused on maximizing the therapeutic value of the innovations we support, ensuring that every project benefits from our enhanced expertise following our integration with NDA Group, the world-leading regulatory firm.

Our core services revolve around the Chief Medical Office and the functions within their purview, including Translational and Clinical Strategies, Medical Affairs, Pharmacovigilance, and Health Economics. By leveraging our deep understanding of these critical areas, we are uniquely positioned to support our clients in navigating the complexities of drug development and commercialization.

This year, we are prioritizing proactive collaboration with our clients to accelerate their success, pushing boundaries in regulatory and clinical strategies to bring groundbreaking therapies to market faster and more efficiently than ever before. Our multidisciplinary teams work hand-in-hand with our clients, providing strategic guidance and operational support to optimize their development programs and maximize the value of their innovations. Our clients' successes are our successes, and we are committed to being the catalyst for their most ambitious goals.

CMAG: What opportunities do you see as the most promising?

When looking at the remainder of this year and 2025, we are incredibly excited about the opportunities ahead for SSI Strategy and the biotech industry as a whole. Despite the challenges faced by the biotech market, we remain optimistic about the potential for innovation and the development of groundbreaking therapies that can make a meaningful impact on patients' lives.

One of the most exciting aspects of our work is the chance to collaborate with innovative biotech companies that are pushing the boundaries of science and medicine. We see tremendous potential in the development of novel therapies for rare and complex diseases, as well as the application of cutting-edge technologies like gene editing, cell therapies, and AI-driven drug discovery

CMAG: What market forces do you see as the most challenging?

We believe that the current market conditions present a unique opportunity for biotech companies to focus on operational efficiency, strategic decision-making, and the optimization of their development programs. By partnering with us, our clients can benefit from our deep industry expertise, our differentiated business model, and our commitment to their success, enabling them to weather market challenges and emerge stronger and better positioned for long-term growth.

CMAG: What impact do you think Best Firm to Work For honors will have on your employees? The firm overall? Clients?

Being recognized on Consulting Magazine's Best Small Firms to Work For list is a great source of pride for our team at SSI Strategy. This recognition has a significant and positive impact on our firm, our employees, and our clients.

For the firm, this recognition serves as a powerful testament to our strong company culture, values, and commitment to employee satisfaction. It validates our efforts to create an environment that fosters collaboration, innovation, and personal growth, and it reinforces our reputation as a leader in the biotech consulting industry. This recognition also helps us attract and retain top talent, as professionals seek out companies known for their outstanding work environments and employee-centric policies.

For our employees, being part of a Best Firm to Work For translates into a more engaging, supportive, and fulfilling work experience. It means that they are valued not just for their skills and expertise but also for their well-being and personal development. Our employees benefit from a culture that prioritizes work-life balance, offers opportunities for professional growth, and encourages open communication and feedback. This positive work environment leads to increased job satisfaction, motivation, and loyalty, which in turn drives better performance and results for our clients.

Finally, our clients reap the benefits of working with a Best Firm to Work For in several ways. First and foremost, they can be confident that they are partnering with a company that attracts and retains the best and brightest minds in the industry. Our ability to create a positive work environment directly translates into the quality of service and expertise we provide to our clients. Happy, engaged employees are more likely to go the extra mile, think creatively, and deliver exceptional results.